TRIM68 Antibody (Monoclonal) (M01) Mouse Monoclonal Antibody Raised Against a Partial Recombinant TRIM68

TRIM68 Antibody (Monoclonal) (M01) Mouse Monoclonal Antibody Raised Against a Partial Recombinant TRIM68

10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 TRIM68 Antibody (monoclonal) (M01) Mouse monoclonal antibody raised against a partial recombinant TRIM68. Catalog # AT4362a Specification TRIM68 Antibody (monoclonal) (M01) - Product Information Application WB, E Primary Accession Q6AZZ1 Other Accession NM_018073 Reactivity Human Host mouse Clonality Monoclonal Isotype IgG2a Kappa Calculated MW 56259 TRIM68 Antibody (monoclonal) (M01) - Additional Information Antibody Reactive Against Recombinant Protein.Western Blot detection against Gene ID 55128 Immunogen (36.74 KDa) . Other Names E3 ubiquitin-protein ligase TRIM68, 632-, RING finger protein 137, SSA protein SS-56, SS-56, Tripartite motif-containing protein 68, TRIM68, GC109, RNF137, SS56 Target/Specificity TRIM68 (NP_060543, 181 a.a. ~ 280 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. Dilution Detection limit for recombinant GST tagged WB~~1:500~1000 TRIM68 is approximately 0.3ng/ml as a capture antibody. Format Clear, colorless solution in phosphate buffered saline, pH 7.2 . TRIM68 Antibody (monoclonal) (M01) - Background Storage Store at -20°C or lower. Aliquot to avoid The protein encoded by this gene contains a repeated freezing and thawing. RING finger domain, a motif present in a variety of functionally distinct proteins and Precautions known to be involved in protein-protein and TRIM68 Antibody (monoclonal) (M01) is for protein-DNA interactions. This gene is research use only and not for use in expressed in many cancer cell lines. Its diagnostic or therapeutic procedures. expression in normal tissues, however, was found to be restricted to prostate. This gene was also found to be differentially expressed in TRIM68 Antibody (monoclonal) (M01) - androgen-dependent versus Page 1/2 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 Protocols androgen-independent prostate cancer cells. Provided below are standard protocols that you TRIM68 Antibody (monoclonal) (M01) - may find useful for product applications. References • Western Blot Genome-wide linkage scans for type 2 • Blocking Peptides diabetes mellitus in four ethnically diverse • Dot Blot populations-significant evidence for linkage on • Immunohistochemistry chromosome 4q in African Americans: the • Immunofluorescence Family Investigation of Nephropathy and • Immunoprecipitation Diabetes Research Group. Malhotra A, et al. • Flow Cytomety Diabetes Metab Res Rev, 2009 Nov. PMID • Cell Culture 19795399.TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Miyajima N, et al. Cancer Res, 2008 May 1. PMID 18451177.The LIFEdb database in 2006. Mehrle A, et al. Nucleic Acids Res, 2006 Jan 1. PMID 16381901.From ORFeome to biology: a functional genomics pipeline. Wiemann S, et al. Genome Res, 2004 Oct. PMID 15489336.The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Gerhard DS, et al. Genome Res, 2004 Oct. PMID 15489334. Page 2/2 Powered by TCPDF (www.tcpdf.org).

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us